Abiopharma

🔍 MARBERGER DAVID S (Director)

Company: LEVI STRAUSS & CO (LEVI)

Report Date: 2026-04-22

Detailed Transactions and Holdings:

• Acquired 8,381 shares of Class A Common Stock (Direct)
  Date: 2026-04-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 31,225.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents the acquisition of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The RSUs will vest in full the earlier of the day before the next annual stockholder meeting or the first anniversary of the grant date.